Here's why the Aconex Ltd share price has gone gangbusters today

The Aconex Ltd (ASX:ACX) share price has been a huge mover today. Is the tech share a buy?

a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

It hasn't been an easy time for shareholders of late, but finally the Aconex Ltd (ASX: ACX) share price is heading in the right direction following a trading update.

At the time of writing the Aconex share price is up 7% to $4.70, bringing its three-month return to a massive 51%.

Why has it rallied?

Much like the iSentia Group Ltd (ASX: ISD) share price rally yesterday, I think the rally in Aconex's shares today is a bit of a relief rally.

Unfortunately Aconex shareholders have had to endure a number of profit downgrades in the last 12 months. This no doubt had many fearing the worst today when it presented at the Macquarie Group Ltd (ASX: MQG) conference.

For the full-year management reiterated its prior guidance of revenue between $160 million and $165 million and EBITDA between $15 million and $18 million.

Ongoing sales momentum across all regions, reduced uncertainty in the UK, improved conditions in United States, and the stabilisation of oil prices are key factors in its guidance.

Furthermore, management continues to expect revenue growth of at least 20% per annum over the medium to long-term.

Should you invest?

Despite all its troubles I do think that Aconex continues to be a great long-term buy and hold investment.

Its cloud collaboration software continues to grow in popularity and it is not hard to see why. Management is of the belief that its platform can accelerate the pace of product delivery and help build five hospitals for the price of four.

That certainly is a compelling value proposition in my eyes.

So although its shares have rallied strongly in the last few months, I believe investors with a long-term view could still find significant value in holding its shares today.

Motley Fool contributor James Mickleboro has no position in any stocks mentioned. The Motley Fool Australia owns shares of ACONEX FPO. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »